Clinical Trial Update: Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Tropocells Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1–2 mild-to-moderate neuroischemic plantar diabetic foot ulc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Neuroischemic Foot Ulcer
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus
• Wound of the Lower Limb

Drugs mentioned

• Tropocells Autologous Platelet-rich Fibrin (PRF) (platelet-rich fibrin)

Snippet

Sponsor: Estar Medical dba Medical Technologies, LTD | Conditions: Diabetic Foot Ulcer, Type 1 Diabetes Mellitus | Phase 2 | Status: RECRUITING